Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Coronary Calcium Testing: Principles and Clinical Application

Right Care Initiative

A. Taylor

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Rivaroxaban's Role in PAD Management: Where Do We Stand?

UPMC

J. Hornick

I Ordered an Lp(a) Level – Now What?

Canadian Collaborative Research Network

M. O'Donoghue

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!

ACC 2024 Insights

S. Mora

Should Statins Be In the Water?

UPMC

S. Mulukutla

Panel Discussion: CEA / TCAR / Carotid Stenting

Transformative Endovascular Decisions Conference

M. Stoner, K. Kasirajan, D. Reid, P. SHAW, R. Sachar, A. Lumsden, W. Zhou